Detecting cord blood cell type-specific epigenetic associations with gestational diabetes mellitus and early childhood growth
- PMID: 34174944
- PMCID: PMC8236204
- DOI: 10.1186/s13148-021-01114-5
Detecting cord blood cell type-specific epigenetic associations with gestational diabetes mellitus and early childhood growth
Abstract
Background: Epigenome-wide association studies (EWAS) have provided opportunities to understand the role of epigenetic mechanisms in development and pathophysiology of many chronic diseases. However, an important limitation of conventional EWAS is that profiles of epigenetic variability are often obtained in samples of mixed cell types. Here, we aim to assess whether changes in cord blood DNA methylation (DNAm) associated with gestational diabetes mellitus (GDM) exposure and early childhood growth markers occur in a cell type-specific manner.
Results: We analyzed 275 cord blood samples collected at delivery from a prospective pre-birth cohort with genome-wide DNAm profiled by the Illumina MethylationEPIC array. We estimated proportions of seven common cell types in each sample using a cord blood-specific DNAm reference panel. Leveraging a recently developed approach named CellDMC, we performed cell type-specific EWAS to identify CpG loci significantly associated with GDM, or 3-year-old body mass index (BMI) z-score. A total of 1410 CpG loci displayed significant cell type-specific differences in methylation level between 23 GDM cases and 252 controls with a false discovery rate < 0.05. Gene Ontology enrichment analysis indicated that LDL transportation emerged from CpG specifically identified from B-cells DNAm analyses and the mitogen-activated protein kinase pathway emerged from CpG specifically identified from natural killer cells DNAm analyses. In addition, we identified four and six loci associated with 3-year-old BMI z-score that were specific to CD8+ T-cells and monocytes, respectively. By performing genome-wide permutation tests, we validated that most of our detected signals had low false positive rates.
Conclusion: Compared to conventional EWAS adjusting for the effects of cell type heterogeneity, the proposed approach based on cell type-specific EWAS could provide additional biologically meaningful associations between CpG methylation, prenatal maternal GDM or 3-year-old BMI. With careful validation, these findings may provide new insights into the pathogenesis, programming, and consequences of related childhood metabolic dysregulation. Therefore, we propose that cell type-specific analyses are worth cautious explorations.
Keywords: Cell type specificity; DNA methylation; Early childhood growth; Epigenome-wide association study; Gestational diabetes mellitus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Maternal pre-pregnancy BMI, offspring epigenome-wide DNA methylation, and childhood obesity: findings from the Boston Birth Cohort.BMC Med. 2023 Aug 23;21(1):317. doi: 10.1186/s12916-023-03003-5. BMC Med. 2023. PMID: 37612641 Free PMC article.
-
DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother-newborn pairs.Clin Epigenetics. 2021 Mar 4;13(1):47. doi: 10.1186/s13148-021-01032-6. Clin Epigenetics. 2021. PMID: 33663600 Free PMC article.
-
Maternal diabetes and obesity influence the fetal epigenome in a largely Hispanic population.Clin Epigenetics. 2020 Feb 19;12(1):34. doi: 10.1186/s13148-020-0824-9. Clin Epigenetics. 2020. PMID: 32075680 Free PMC article.
-
DNA methylation changes in cord blood and the developmental origins of health and disease - a systematic review and replication study.BMC Genomics. 2022 Mar 19;23(1):221. doi: 10.1186/s12864-022-08451-6. BMC Genomics. 2022. PMID: 35305575 Free PMC article.
-
Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.PLoS Med. 2023 Jul 6;20(7):e1004247. doi: 10.1371/journal.pmed.1004247. eCollection 2023 Jul. PLoS Med. 2023. PMID: 37410739 Free PMC article. Review.
Cited by
-
The potential utility of cord blood DNA methylation in pediatric clinical practice.Epigenomics. 2024 Nov-Nov;16(21-22):1365-1372. doi: 10.1080/17501911.2024.2408217. Epub 2024 Nov 12. Epigenomics. 2024. PMID: 39530586
-
Nucleated red blood cells explain most of the association between DNA methylation and gestational age.Commun Biol. 2023 Feb 27;6(1):224. doi: 10.1038/s42003-023-04584-w. Commun Biol. 2023. PMID: 36849614 Free PMC article.
-
Deciphering DNA Methylation in Gestational Diabetes Mellitus: Epigenetic Regulation and Potential Clinical Applications.Int J Mol Sci. 2024 Aug 29;25(17):9361. doi: 10.3390/ijms25179361. Int J Mol Sci. 2024. PMID: 39273309 Free PMC article. Review.
-
Association of DNA Methylation with Infant Birth Weight in Women with Gestational Diabetes.Metabolites. 2024 Jun 27;14(7):361. doi: 10.3390/metabo14070361. Metabolites. 2024. PMID: 39057684 Free PMC article. Review.
-
Preterm birth buccal cell epigenetic biomarkers to facilitate preventative medicine.Sci Rep. 2022 Mar 1;12(1):3361. doi: 10.1038/s41598-022-07262-9. Sci Rep. 2022. PMID: 35232984 Free PMC article.